Clinical Trial Update: A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin

View source ↗

Summary

This entry notes the completion of a multi-center observational safety registry evaluating Parkinson's disease patients who were previously treated with intrapu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Parkinson Disease

Drugs mentioned

• Liatermin (r-metHuGDNF)

Snippet

Sponsor: Amgen | Conditions: Idiopathic Parkinson's Disease | Status: COMPLETED